The Change of Serum Interleukin-6 Fails to Identify Subsequent Periprosthetic Joint Infection in Patients Who Have Two-Stage Revision for Periprosthetic Joint Infection
The Journal of Arthroplasty · 2023-12 · 38 (12) · 2698-2703
DOI: 10.1016/j.arth.2023.06.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Arthroplasty, 2023-12. Verfasst von Johanna S Krueger und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics and Tumor Orthopaedics, Muenster University Hospital, Muenster, Germany. Hauptthemen laut MEDLINE: Prosthesis-Related Infections, Arthroplasty, Replacement, Knee, Arthroplasty, Replacement, Hip, Arthritis, Infectious. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The diagnosis of persistent infection prior to second-stage reimplantation in 2-stage exchanges for periprosthetic joint infection (PJI) can be challenging as there is no optimal diagnostic tool. This study investigates the usefulness of pre-reimplantation serum C-reactive protein (CRP) and interleukin-6 (IL-6) and its change between both stages to identify patients who have subsequent PJI. METHODS: There were 125 patients who underwent planned 2-stage exchange for chronic knee or hip PJI from a single center retrospectively identified. Patients were included if preoperative CRP and IL-6 were available for both stages. Subsequent PJI was defined as 2 positive microbiological cultures at reimplantation or subsequent surgery or death due to PJI during follow-up. RESULTS: Prior to reimplantation, the median serum CRP (total knee arthroplasties [TKAs]: 1.0 versus 0.5 mg/dL, P = .028; total hip arthroplasties [THAs]: 1.3 versus 0.5 mg/dL, P = .015) and median IL-6 (TKA: 8.0 versus 6.0 pg/mL, P = .052; THA: 7.0 versus 6.0 pg/mL, P = .239) were higher in patients who had subsequent PJI. The IL-6 and CRP values showed moderate sensitivity (TKA/CRP: 66.7%; THA/CRP: 58.8%; TKA/IL-6: 46.7%; THA/IL-6: 35.3%) and good specificity (TKA/CRP: 66.7%; THA/CRP: 81.0%; TKA/IL-6: 86.3%; THA/IL-6: 83.3%). The change in CRP and IL-6 between the stages did not differ between the groups, respectively. CONCLUSIONS: Serum CRP and IL-6 show low to moderate sensitivity and good specificity in the diagnosis of subsequent PJI prior to reimplantation, which questions their usefulness as a rule-out test. Furthermore, the change in between stages does not appear to identify subsequent PJI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics and Tumor Orthopaedics, Muenster University Hospital, Muenster, Germany.
Zitieren
APA
Krueger, J. S., Ackmann, T., Gosheger, G., Moellenbeck, B., Puetzler, J., & Theil, C. (2023). The Change of Serum Interleukin-6 Fails to Identify Subsequent Periprosthetic Joint Infection in Patients Who Have Two-Stage Revision for Periprosthetic Joint Infection. The Journal of Arthroplasty, 38(12), 2698-2703. https://doi.org/10.1016/j.arth.2023.06.008
Vancouver
Krueger JS, Ackmann T, Gosheger G, Moellenbeck B, Puetzler J, Theil C. The Change of Serum Interleukin-6 Fails to Identify Subsequent Periprosthetic Joint Infection in Patients Who Have Two-Stage Revision for Periprosthetic Joint Infection. The Journal of Arthroplasty. 2023;38(12):2698-2703. doi:10.1016/j.arth.2023.06.008
BibTeX
@article{Krueger2023,
author = {Krueger, Johanna S and Ackmann, Thomas and Gosheger, Georg and Moellenbeck, Burkhard and Puetzler, Jan and Theil, Christoph},
title = {The Change of Serum Interleukin-6 Fails to Identify Subsequent Periprosthetic Joint Infection in Patients Who Have Two-Stage Revision for Periprosthetic Joint Infection},
journal = {The Journal of Arthroplasty},
year = {2023},
volume = {38},
number = {12},
pages = {2698--2703},
doi = {10.1016/j.arth.2023.06.008}
}
EUVIMED